http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2401917-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a899eba0e35112cc25b4aa1b0b7fda90
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-82
filingDate 1978-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c037aeeee7ff22509ab96a839aca9e7
publicationDate 1979-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2401917-A1
titleOfInvention PROCESS FOR PREPARING 4-ARYL-2 (1H) -QUINAZOLINONES
abstract The subject of the invention is a process for the preparation of 4-aryl-2 (1H) -quinazolinones by dehydrogenation of the corresponding tetrahydro-quinazolinones with sulfur in an inert organic solvent. According to the process of the invention, the dehydrogenation is carried out in the presence of an inorganic metal compound consisting of an oxide, a hydroxide or a salt of a metal other than magnesium, aluminum or an alkali metal, and capable of forming a metal sulfide under the reaction conditions. The new process makes it possible to prepare 4-aryl-2 (1H) -quinazolinones used as anti-inflammatory agents.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2435463-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2465726-A1
priorityDate 1977-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2254325-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20494721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422800739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID344381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421360260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402

Total number of triples: 29.